Skip to content

Comparison of the effect of anti-osteoporosis therapies on the repair of osteoporotic fractures

Comparison of the effect of anti-osteoporosis therapies on the repair of osteoporotic fractures in patientss admitted to the orthopedic ward

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160830029603N6
Enrollment
75
Registered
2018-01-24
Start date
2017-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis. Osteoporosis with current pathological fracture

Interventions

Intervention 1: ?First Intervention group: Calcium and Vitamin D with parathyroid hormone branded Sinopar. Intervention 2: Second Intervention group: Calcium and Vitamin D with Alendoronite made at
Treatment - Drugs
?First Intervention group: Calcium and Vitamin D with parathyroid hormone branded Sinopar
Second Intervention group: Calcium and Vitamin D with Alendoronite made at a dose of 70 milligrams
Control group: Calcium and Vitamin D

Sponsors

Sari University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 50 years old Patients with a sudden fracture of the wrist, vertebra or hip with Tscore less than 2.5 - who have undergone a Corrective surgical procedure Do not take anti-osteoporosis drugs including bisphosphonate, calcitonin, raloxifene, and parathyroid hormone over the past 6 months before fracture

Exclusion criteria

Exclusion criteria: Previous history of osteoporotic fractures Multiple trauma Cancer Other diseases requiring aggressive, corticosteroid, or immunosuppressive therapy Selective arthroplasty

Design outcomes

Primary

MeasureTime frame
The rate of fracture restoration. Timepoint: the assessment of fracture restoration in weeks 4, 8 and 12 after surgery. Method of measurement: Radiography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDoctor Saber Joor Ebrahimian

Sari University of Medical Sciences

shayestehazar@mazums.ac.ir+98 11 3337 7169

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026